Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublinesin vitro
- 1 September 1994
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 12 (3) , 169-182
- https://doi.org/10.1007/bf00873957
Abstract
Thein vitro cytotoxic effects of docetaxel (Taxotere®; RP56976, NSC688503) proved both time and concentration dependent. Amongst thirteen human cell lines from various tumor types, exposure to increasing concentrations of docetaxel over 24 hrs resulted in a plateau-shaped dose response curve, suggesting that increased cell kill becomes more dependent on increased exposure duration than on concentration. IC50 concentrations (reducing survival by 50%) ranged from 0.13–3.3 ng/ml, with three neuroblastoma lines proving most sensitive and three breast and two colon carcinoma lines showing least sensitivity. There was significant cross-resistance to docetaxel in the classic multidrug resistant (MDR) Chinese hamster ovarian (CHO) CHRC5 line and the human lymphoblastoid CCRF-CEMVLB1000 line, as well as in two vincristine(VCR)-selected MDR MCF-7 sublines. All four of these MDR sublines overexpress P-glycoprotein (Pgp), as did a 6fold docetaxel-selected resistant CHO subline. As an apparent corollary, in two human teratoma lines selected for etoposide resistance and showing some cross-resistance to VCR and in two CHO sublines expressing low levels of VCR resistance, yet all proving Pgp positive, no docetaxel crossresistance was identified. Verapamil modulated docetaxel resistance only in sublines expressing resistance to the drug and overexpressing Pgp. Four other human tumor sublines selected for resistance to 5-fluorouracil, cisplatin or teniposide, showed a lack of cross-resistance to docetaxel. Furthermore, cross-resistance to docetaxel was not apparant in four epipodophyllotoxin-selected resistant sublines with alterations in topoisomerase II, indicating its effectiveness against tumor cells expressing the topoisomerase II-related MDR phenotype. Our observation that docetaxel cross-resistance was not automatically expressed by classic MDR tumour cells appears of interest and of potential clinical relevance.Keywords
This publication has 49 references indexed in Scilit:
- Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agentsEuropean Journal Of Cancer, 1993
- Characterization of the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster ovary cells following their in-vitro exposure to fractionated X-irradiationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Phase I Trial of Taxotere: Five-Day ScheduleJNCI Journal of the National Cancer Institute, 1992
- Expression off resistance to etoposide and vincristine in vitro and in vivo after X-irradiation of ovarian tumor cellsAnti-Cancer Drugs, 1992
- Effects of taxotere on murine and human tumor cell linesBiochemical and Biophysical Research Communications, 1992
- Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitroCarcinogenesis: Integrative Cancer Research, 1992
- Overexpression of P-glycoprotein in Mammalian Tumor Cell Lines After Fractionated X Irradiation In VitroJNCI Journal of the National Cancer Institute, 1990
- Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studiesInternational Journal of Cancer, 1987
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Establishment and characterization of a cell line of human breast carcinoma originPublished by Elsevier ,1979